Titre :
  • Phase I study of docetaxel administered as a 1-hour intravenous infusion on a weekly basis.
Auteur : Tomiak, E ; Piccart-Gebhart, Martine ; Kerger, Joseph ; Lips, S ; Awada, Ahmad ; De Valeriola, Dominique ; Ravoet, Christophe ; Lossignol, Dominique ; Sculier, Jean-Paul ; Auzannet, V
Informations sur la publication : Journal of clinical oncology, 12, 7, (page 1458-1467)
Statut de publication : Publié, 1994-07
Sujet CREF : Sciences bio-médicales et agricoles
Mots-clés MeSH : Adult
Antineoplastic Agents, Phytogenic -- administration & dosage
Antineoplastic Agents, Phytogenic -- adverse effects
Antineoplastic Agents, Phytogenic -- pharmacokinetics
Drug Administration Schedule
Female
Humans
Infusions, Intravenous
Male
Middle Aged
Neoplasms -- drug therapy
Paclitaxel -- administration & dosage
Paclitaxel -- adverse effects
Paclitaxel -- analogs & derivatives
Paclitaxel -- pharmacokinetics
Taxoids
Treatment Outcome
Note : Clinical Trial
Clinical Trial, Phase I
Controlled Clinical Trial
Journal Article
Research Support, Non-U.S. Gov't
Langue :
  • Anglais
Identificateurs : urn:issn:0732-183X 
info:pmid/7912725